1,387
Views
93
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Effects of Probiotic Yogurt on Fat Distribution and Gene Expression of Proinflammatory Factors in Peripheral Blood Mononuclear Cells in Overweight and Obese People with or without Weight-Loss Diet

, PhD, , , , , , BS, , BS, , , MS, , PhD & , PhD show all
Pages 417-425 | Received 20 Apr 2013, Accepted 30 Aug 2013, Published online: 31 Jul 2014

REFERENCES

  • Gnacińska M, Małgorzewicz S, Guzek M, Lysiak-Szydłowska W, Sworczak K: Adipose tissue activity in relation to overweight or obesity. Polish J Endocrinol 61(2):160–168, 2010.
  • Matarese G, Procaccini C, De Rosa V, Horvath TL, La Cava A: Regulatory T cells in obesity: the leptin connection. Trends Mol Med 16:247–256, 2010.
  • Fantuzzi G: Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 115:911–919, 2005.
  • O’Rahilly S: Human genetics illuminates the paths to metabolic disease. Nature 462:307–314, 2009.
  • Turnbaugh PJ, Hamady M, Yatsunenko T: A core gut microbiome in obese and lean twins. Nature 457:480–484, 2008.
  • Zoetendal EG, Rajilic-Stojanovic M, de Vos WM: High-through put diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57:1605–1615, 2008.
  • Niers LEM, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NOP, Knol EF, Kapsenberg ML, Kimpen JLL, Hoekstra MO: Identification of strong interleukin‐10 inducing lactic acid bacteria which down‐regulate T helper type 2 cytokines. Clin Exp Allergy 35:1481–1489, 2005.
  • Vitali B, Ndagijimana M, Cruciani F, Carnevali P, Candela M, Guerzoni ME, Brigidi P: Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 10:4, 2010.
  • Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 361:512–519, 2003.
  • Bleau C, Lamontagne L, Savard R: New Lactobacillus acidophilus isolates reduce the release of leptin by murine adipocytes leading to lower interferon‐γ production. Clin Exp Immunol 140:427–435, 2005.
  • Sumarac-Dumanovic M, Stevanovic D, Ljubic A: Increased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women. Int J Obes 33:151–156, 2008.
  • Miljkovic D, Trajkovic V: Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev 15:21–32, 2004.
  • Uyeno Y, Sekiguchi Y, Kamagata Y: Impact of consumption of probiotic lactobacilli-containing yogurt on microbial composition in human feces. Int J Food Microbiol 122:16–22, 2008.
  • Reiff C, Delday M, Rucklidge G, Reid M, Duncan G: Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a bio therapeutic agent, in the treatment of inflammatory bowel disease. Inflamm Bowel Dis 15:1721–1736, 2009.
  • Lam B, Younossi ZM: Treatment options for nonalcoholic fatty liver disease. Therap Adv Gastroenterol 3:121–137, 2010.
  • Zhang Y, Ma D, Tian Y, Wang X, Qiao Y, Cui B: The imbalance of Th17/Treg in patients with uterine cervical cancer. Clin Chim Acta 412:894–900, 2011.
  • Romero-Corral A, Somers VK, Sierra-Johnson J, Thomas RJ, Collazo-Clavell ML, Korinek J, Allison TG, Batsis JA, Sert-Kuniyoshi FH, Lopez-Jimenez F: Accuracy of body mass index in diagnosing obesity in the adult general population. Int J Obes 32:959–966, 2008.
  • Hagstromer M, Oja P, Sjostrom M: The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. Public Health Nutr 9:755–762, 2006.
  • Veenbergen S, Samsom JN: Maintenance of small intestinal and colonic tolerance by IL-10-producing regulatory T cell subsets. Curr Opin Immunol 24:269–276, 2012.
  • An HM, Park SY, Lee do K, Kim JR, Cha MK: Anti-obesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis 10:116, 2011.
  • Hamad EM, Sato M, Uzu K, Yoshida T, Higashi S, Kawakami H, Kadooka Y, Matsuyama H, Abd El-Gawad IA, Imaizumi K: Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats. Br J Nutr 101:716–724, 2009.
  • Ma X, Hua J, Li Z: Probiotics improve high fat diet–induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol 49:821–830, 2008.
  • Lee HY, Park JH, Seok SH, Baek MW, Kim DJ, Lee KE, Paek KS, Lee Y, Park JH: Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Mol Cell Biol Lipids 1761:736–744, 2006.
  • Yin YN, Yu QF, Fu N, Liu XW, Lu FG: Effects of four bifidobacteria on obesity in high-fat diet induced rats. World J Gastroenterol 16:3394–3401, 2010.
  • Maury J, Issad T, Perdereau D, Gouhot B, Ferre P, Girard J: Effect of acarbose on glucose homeostasis, lipogenesis and lipogenic enzyme gene expression in adipose tissue of weaned rats. Diabetologia 36:503–509, 1993.
  • Kang JH, Yun SI, Park HO: Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats. J Microbiol 48:712–714, 2010.
  • Xie N, Cui Y, Yin Y-N, Zhao X, Yang J-W, Wang ZG, Fu N, Tang Y, Wang XH, Liu XW, Wang CL, Lu FG: Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complement Altern Med 11:53, 2011.
  • Sato M, Uzu K, Yoshida T, Hamad EM, Kawakami H, Matsuyama H, Abd El-Gawad IA, Imaizumi K: Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 99:1013–1017, 2008.
  • Wing R, Sinha M, Considine R, Lang W, Caro J. Relationship between weight loss maintenance and changes in serum leptin levels. Horm Metab 28:698–703, 1996.
  • Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S: Leptin levels in human and rodent: measures of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 11:1155–1161, 1995.
  • Kolaczynski JW, Considine RV, Ohannesian J, Marco C, Opentanova I, Nyce MR, Myint M, Caro JF: Responses of leptin to short-term fasting and refeeding in humans: a link with ketogenesis but not ketones themselves. Diabetes 45:1511–1515, 1996.
  • Boden G, Chen X, Mozzoli M, Ryan I: Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 81:3419–3423, 1996.
  • Kekkonen RA, Lummela N, Karjalainen H, Latvala S, Tynkkynen S, Jarvenpaa S, Kautiainen H, Julkunen I, Vapaatalo H, Korpela R: Probiotic intervention has strain-specific anti-inflammatory effects in healthy adults. World J Gastroenterol 14:2029–2036, 2008.
  • Chu N, Spiegelman D, Rifai N, Hotamisligil G, Rimm E: Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes 24:1085–1092, 2000.
  • Mantzoros CS, Moschos S, Avramopoulos I, Kaklamani V, Liolios A, Doulgerakis DE, Griveas I, Katsilambros N, Flier JS: Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans. J Clin Endocrinol Metab 82:3408–3413, 1997.
  • Zhang HH, Kumar S, Barnett AH, Eggo MC: Tumour necrosis factor-α exerts dual effects on human adipose leptin synthesis and release. Mol Cell Endocrinol 159:79–88, 2000.
  • Bilan PJ, Samokhvalov V, Koshkina A, Schertzer JD, Samaan MC, Klip A: Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells. Arch Physiol Biochem 115(4):176–190, 2009.
  • Bourlier V, Bouloumié A: Role of macrophage tissue infiltration in obesity and insulin resistance. Diabetes Metab 35:251–260, 2009.
  • Lumeng CN, Maillard I, Saltiel AR: T-ing up inflammation in fat. Nat Med 15:846–847, 2009.
  • Vojdani A, Lambert J, Kellermann G: The role of Th17 in neuro immune disorders: a target for CAM therapy. Part III. Evid Based Complement Altern Med 1–11, 2011.
  • Rajendran K, Devarajan N, Ganesan M, Ragunathan M: Obesity, inflammation and acute myocardial infarction—expression of leptin, IL-6 and high sensitivity-CRP in Chennai based population. Thromb J 10:13, 2012.
  • Jager A, Kuchroo VK: Effector and regulatory T-cell subsets in autoimmunity and tissue inflammation. Scand J Immunol 72:173–184, 2010.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.